Literature DB >> 3152513

Ultrasonographic diagnosis of submucosal tumors of the stomach: the "bridging layers" sign.

Y Miyamoto1, F Tsujimoto, S Tada.   

Abstract

The ultrasonic findings in 14 cases with submucosal tumors and one case with extragastric lymphoma using the fluid-filled stomach method were reviewed to determine the appearance of the stomach wall in submucosal tumors. Two characteristic ultrasound features of submucosal tumors were demonstrated in all 14 lesions except in two located high in the fundus of the stomach. One feature was mucosal bridging layers, i.e., three layers could be seen on the mucosal side of the tumors, and at least two of them continued to layers 1 and 2 of the normal gastric wall. The other was a serosal bridging layer, i.e., layer 5 of the normal gastric wall ran toward the serosal side of the tumor. On the basis of a "bridging layers" sign, we believe a definite diagnosis of submucosal tumor can be obtained from ultrasound images.

Entities:  

Mesh:

Year:  1988        PMID: 3152513     DOI: 10.1002/jcu.1870160407

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  4 in total

Review 1.  Basic practices for gastrointestinal ultrasound.

Authors:  Mutsumi Nishida; Yuichi Hasegawa; Jiro Hata
Journal:  J Med Ultrason (2001)       Date:  2022-09-10       Impact factor: 1.878

2.  Diffuse heterotopic submucosal cystic malformation of the stomach: ultrasonographic diagnosis.

Authors:  M Niizawa; H Ishida; P Morikawa; H Watanabe; O Masamune
Journal:  Gastrointest Radiol       Date:  1992

3.  Gastric Schwannoma: A Tumor Must Be Included in Differential Diagnoses of Gastric Submucosal Tumors.

Authors:  Bao-Guang Hu; Feng-Jie Wu; Jun Zhu; Xiao-Mei Li; Yu-Ming Li; Yan Feng; He-Sheng Li
Journal:  Case Rep Gastrointest Med       Date:  2017-05-09

4.  Is it worthwhile to fully evaluate the stomach in every ultrasound examination of the abdominal cavity?

Authors:  M Goudarzi; J Navabi; Gh Salimi
Journal:  Iran J Radiol       Date:  2011-03-30       Impact factor: 0.212

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.